Pharmaceutical Technology1 天
Suplatast tosilate by Melius Pharma for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
Suplatast tosilate is under clinical development by Melius Pharma and currently in Phase II for Idiopathic Pulmonary Fibrosis.
Pharmaceutical Technology1 天
Suplatast tosilate by Melius Pharma for Cough: Likelihood of Approval
Suplatast tosilate is an an immunoregulatory compound. It is formulated as hard gelatin capsules and dry syrup for oral route of administration. It is under development for idiopathic pulmonary ...